HPA Axis: New Clinical Developments

OR21-1

HLA markers, DQ8 and DRw53, Associate with Lymphocytic Hypophysitis and May Aid Diagnosis
Anthony P Heaney, Marvin Bergsneider, Brittany Sumerel and Linda Liau

OR21-2

CHARACTERIZATION OF AUTOIMMUNE DISORDERS IN PATIENTS WITH ENDOGENOUS CUSHING'S SYNDROME: A MULTICENTER ITALIAN STUDY
Federica Guaraldi, Martina De Martin, Carla Maria Scaroni, Maria Luisa Zilio, Francesca Pecori Giraldi, Ioannis Karamouzis, Silvia Grottoli, Ezio Ghigo and Emanuela Arvat

OR21-3

The Endocrine-Immune Response to Severe Trauma
Mark Foster, Neil Hill, Abigail A Routledge, Conor Bentley, Donna M O'Neil, Julian F Bion, Mark M Midwinter, Joanne L Fallowfield and Janet M Lord

OR21-4

Increased Hypothalamic-Pituitary-Adrenal Drive is Associated with Decreased Appetite and Hypoactivation of Food Motivation Neurocircuitry in Anorexia Nervosa
Elizabeth A. Lawson, Laura M Holsen, Rebecca DeSanti, McKale Santin, Erinne Neubecker Meenaghan, David B Herzog, Jill M Goldstein and Anne Klibanski

OR21-5

Low ACTH-stimulated plasma corticosterone may contribute to elevated plasma cortisol in people with metabolic syndrome
Scott D Mackenzie, Rebecca M Reynolds, Jennifer Bolton, Jim Wilson, David Ivor Wyn Phillips and Brian R Walker

OR21-6

Clinical phenotype of patients with MCM4 mutation suggests pubertal delay in males
Claire R Hughes, Jean Dunne, Owen Smith, Emmanuelle Jouanguy, Louise A Metherell, Jean-Laurent Casanova, Con Feighery, Adrian J L Clark and Colm Costigan